SIBN

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

14.600

Open

14.390

VWAP

14.43

Vol

277.69K

Mkt Cap

614.30M

Low

14.330

Amount

4.01M

EV/EBITDA(TTM)

Total Shares

41.20M

497.16M

EV/OCF(TTM)

P/S(TTM)

3.57

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q1

FY2025Q2

FY2025Q3

45.13M

+19.18%

-0.217

-19.44%

46.71M

+16.87%

-0.189

-14.2%

46.21M

+14.56%

-0.164

+2.34%

Estimates Revision

The market is revising Upward the revenue expectations for SI-BONE, Inc. (SIBN) for FY2025, with the revenue forecasts being adjusted by 0.41% over the past three months. During the same period, the stock price has changed by -15.97%.

Revenue Estimates for FY2025

Revise Upward

+0.41%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+9.27%

In Past 3 Month

Stock Price

Go Down

-15.97%

In Past 3 Month

8 Analyst Rating

67.86% Upside

Wall Street analysts forecast SIBN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SIBN is 24.29 USD with a low forecast of 19.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

8 Buy

0 Hold

0 Sell

Strong Buy

67.86% Upside

Current: 14.470

Low

19.00

Averages

24.29

High

32.00

67.86% Upside

Current: 14.470

Low

19.00

Averages

24.29

High

32.00

Needham

David Saxon

Strong Buy

Reiterates

$19

2025-01-13

Reason

Needham

David Saxon

Price Target

$19

2025-01-13

Reiterates

Strong Buy

Reason

Needham

David Saxon

Strong Buy

Reiterates

$19

2024-11-20

Reason

Needham

David Saxon

Price Target

$19

2024-11-20

Reiterates

Strong Buy

Reason

Needham

David Saxon

Strong Buy

Reiterates

$19

2024-11-13

Reason

Needham

David Saxon

Price Target

$19

2024-11-13

Reiterates

Strong Buy

Reason

Truist Securities

Samuel Brodovsky

Strong Buy

Maintains

$16 → $18

2024-11-13

Reason

Truist Securities

Samuel Brodovsky

Price Target

$16 → $18

2024-11-13

Maintains

Strong Buy

Reason

Truist Securities

Samuel Brodovsky

Strong Buy

Maintains

$18 → $16

2024-10-14

Reason

Truist Securities

Samuel Brodovsky

Price Target

$18 → $16

2024-10-14

Maintains

Strong Buy

Reason

Truist lowered the firm's price target on SI-Bone to $16 from $18 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results for the MedTech sector. While the firm believes that any hurricane related headwind call-outs for Q4 will generally get "a pass" from investors, it could cause companies with elective or deferrable procedure areas to see more muted guide increases, the analyst tells investors in a research note. For the stock, Truist contends that it sees a modest Q3 revenue beat while noting Si-Bone's operational catalysts that include "TORQ TNT for pelvic fracture launch" and achieving positive EBITDA in Q4 that generally create a good setup heading into the print.

Needham

David Saxon

Strong Buy

Maintains

$27 → $19

2024-08-06

Reason

Needham

David Saxon

Price Target

$27 → $19

2024-08-06

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for SI-BONE Inc (SIBN.O) is -21.27, compared to its 5-year average forward P/E of -16.22. For a more detailed relative valuation and DCF analysis to assess SI-BONE Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-16.22

Current PE

-21.27

Overvalued PE

-11.58

Undervalued PE

-20.85

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

38.29

Current EV/EBITDA

246.06

Overvalued EV/EBITDA

378.77

Undervalued EV/EBITDA

-302.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

5.96

Current PS

3.15

Overvalued PS

8.35

Undervalued PS

3.57

Financials

Annual

Quarterly

FY2024Q4

YoY :

+26.10%

49.00M

Total Revenue

FY2024Q4

YoY :

-56.07%

-5.49M

Operating Profit

FY2024Q4

YoY :

-59.07%

-4.50M

Net Income after Tax

FY2024Q4

YoY :

-59.26%

-0.11

EPS - Diluted

FY2024Q4

YoY :

-67.91%

-1.09M

Free Cash Flow

FY2024Q4

YoY :

+7.22%

79.13

Gross Profit Margin - %

FY2024Q4

YoY :

-28.18%

-13.71

FCF Margin - %

FY2024Q4

YoY :

-67.55%

-9.17

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

137.8K

USD

3-6

Months

1.6M

USD

6-9

Months

402.4K

USD

0-12

Months

257.9K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 457520.97% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

1.1M

Volume

Months

6-9

0.0

Volume

Months

0-12

248.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

137.8K

USD

3-6

Months

1.6M

USD

6-9

Months

402.4K

USD

0-12

Months

257.9K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

SIBN News & Events

Events Timeline

2025-02-24 (ET)

2025-02-24

16:24:50

SI-Bone sees FY25 revenue $193.5M-$195.5M, consensus $193.47M

2025-02-24

16:24:10

SI-Bone reports Q4 EPS (11c), consensus (13c)

2024-11-12 (ET)

2024-11-12

16:32:12

SI-Bone narrows FY24 revenue view to $165M-$166M from $165M-$167M

News

6.0

04-17Investing.com

Russian Arctic oil exports to China jump helped by STS transfers, sources say By Reuters

2.0

03-14Benzinga

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session

9.5

03-14Benzinga

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

People Also Watch

FISI

Financial Institutions Inc

HarborOne Bancorp Inc

Insteel Industries Inc

Mind Medicine (MindMed) Inc

Midland States Bancorp Inc

16.560

USD

-0.30%

FAQ

What is SI-BONE Inc (SIBN) stock price today?

The current price of SIBN is 14.47 USD — it has increased 0.42 % in the last trading day.

SIBN

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

SIBN News & Events

Events Timeline

News

People Also Watch

FAQ

What is SI-BONE Inc (SIBN) stock price today?

What is SI-BONE Inc (SIBN)'s business?

What is the price predicton of SIBN Stock?

What is SI-BONE Inc (SIBN)'s revenue for the last quarter?

What is SI-BONE Inc (SIBN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for SI-BONE Inc (SIBN)'s fundamentals?

How many employees does SI-BONE Inc (SIBN). have?

What is SI-BONE Inc (SIBN) market cap?